Showing results (1161-1170 of 1,246) with videos related to
Sort By:
Pageof 125
The American Psychologist|June 29, 2023
Standing on the shoulders of a giant: The legacy of Robert M. SellersAmber D Williams, Krista Maywalt Aronson, Tabbye M Chavous, et al.Journal of Virology|April 24, 2020
Defective Influenza A Virus RNA Products Mediate MAVS-Dependent Upregulation of Human Leukocyte Antigen Class I ProteinsMir Munir A Rahim, Brendon D Parsons, Emma L Price, et al.JAMA Network Open|April 11, 2025
Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial VirusNardin Kirolos, Haifa Mtaweh, Rohini R Datta, et al.Jac-Antimicrobial Resistance|August 29, 2025
Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensusSabine Bou-Antoun, Rebecca C Oettle, Alistair Leanord, et al.Nature Immunology|September 24, 2021
The transcription factor CREB1 is a mechanistic driver of immunogenicity and reduced HIV-1 acquisition following ALVAC vaccinationJeffrey Alan Tomalka, Adam Nicolas Pelletier, Slim Fourati, et al.Journal of Virology|February 1, 2019
Rare Detection of Antiviral Functions of Polyclonal IgA Isolated from Plasma and Breast Milk Compartments in Women Chronically Infected with HIV-1Matthew Zirui Tay, Erika L Kunz, Aaron Deal, et al.Diabetes Research and Clinical Practice|February 4, 2026
Survey of glucose levels in adults with T1DM attending clinic using automated insulin delivery (AID) devices compared with manual insulin deliveryKate M Seaton, Hanna C Jones, Melissa H Lee, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2022
Safety and Pharmacokinetics of Intravenous 10-1074 and VRC01LS in Young ChildrenEdmund V Capparelli, Gbolahan Ajibola, Kenneth Maswabi, et al.Plos Medicine|November 15, 2017
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trialKenneth H Mayer, Kelly E Seaton, Yunda Huang, et al.The Journal of Infectious Diseases|January 10, 2014
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesPaul A Goepfert, Marnie L Elizaga, Kelly Seaton, et al.Pageof 125